key: cord-0888168-sqxlnk9e
authors: Park, Jiyeon; Yoo, Seung Yeon; Ko, Jae-Hoon; Lee, Sangmin M.; Chung, Yoon Joo; Lee, Jong-Hwan; Peck, Kyong Ran; Min, Jeong Jin
title: Infection Prevention Measures for Surgical Procedures during a Middle East Respiratory Syndrome Outbreak in a Tertiary Care Hospital in South Korea
date: 2020-01-15
journal: Sci Rep
DOI: 10.1038/s41598-019-57216-x
sha: 8857ba8944f2ae93f5af2424992a8cfcac85765a
doc_id: 888168
cord_uid: sqxlnk9e

In 2015, we experienced the largest in-hospital Middle East respiratory syndrome (MERS) outbreak outside the Arabian Peninsula. We share the infection prevention measures for surgical procedures during the unexpected outbreak at our hospital. We reviewed all forms of related documents and collected information through interviews with healthcare workers of our hospital. After the onset of outbreak, a multidisciplinary team devised institutional MERS-control guidelines. Two standard operating rooms were converted to temporary negative-pressure rooms by physically decreasing the inflow air volume (−4.7 Pa in the main room and −1.2 Pa in the anteroom). Healthcare workers were equipped with standard or enhanced personal protective equipment according to the MERS-related patient’s profile and symptoms. Six MERS-related patients underwent emergency surgery, including four MERS-exposed and two MERS-confirmed patients. Negative conversion of MERS-CoV polymerase chain reaction tests was noticed for MERS-confirmed patients before surgery. MERS-exposed patients were also tested twice preoperatively, all of which were negative. All operative procedures in MERS-related patients were performed without specific adverse events or perioperative MERS transmission. Our experience with setting up a temporary negative-pressure operation room and our conservative approach for managing MERS-related patients can be referred in cases of future unexpected MERS outbreaks in non-endemic countries.

high-volume healthcare facility, which is how the previous South Korea outbreak occurred 11 . Moreover, there may be very few hospitals that are prepared to provide perioperative care for MERS patients. Therefore, herein, we share our experience of providing infection prevention and control measures for surgeries for MERS-related patients in our hospital.

During the MERS outbreak in our hospital, six MERS-related patients underwent surgery including three possibly exposed patients, one directly exposed patient, and two MERS-confirmed patients who recovered from the disease. All patients were negative during two preoperative MERS screenings using real-time reverse transcription polymerase chain reaction (rRT-PCR) 14 . Figure 1 shows the total number of surgeries performed during the outbreak period at our hospital and the distribution of MERS-related patients undergoing surgery.

Temporary set-up of a negative-pressure operating room. The operating rooms in our hospital were generally positive-pressure environments, and we had no permanent negative-pressure operating rooms. Because a negative-pressure operating room is the optimal environment to prevent airborne virus spreading to adjacent areas 13 , two of our 25 operating rooms in the main operating suite of the hospital were temporarily converted into negative-pressure operating rooms to perform surgical procedures on MERS-related patients. Operating rooms no. 16 and 17 were selected because they were connected to each other, but each room had separate atmospheric air inlets and exhaust systems. They also had separate air-conditioning and humidification systems. Of the two connected rooms, one was used as the main operating room and the other was used as the anteroom where healthcare workers (HCWs) applied and removed the personal protective equipment (PPE).

In each room, fresh air was supplied from an inlet duct and discharged outside through the exhaust duct (Fig. 2) . Because a constant exhausting air volume was maintained through the outlet duct, negative pressure in the operating room was achieved by decreasing the inflow air volume that entered through the inlet duct. First, the blades of the air volume control damper in the inlet duct were closed as much as possible (Fig. 2) . However, because the damper was not intended to be air-tight, the inflow volume to the operating room did not decrease sufficiently. Second, as an additional measure to decrease the inflow volume, we opened the access hole in the inlet duct, which was originally used for duct inspection purposes (Fig. 2) . Finally, a smoke test was carried out to ensure negative pressure. The room pressure was maintained at −4.7 Pa in the main operating room and at −1.2 Pa in the anteroom (Fig. 3) ; −4.7 Pa is below the negative pressure room standard of −2.5 Pa 15 . www.nature.com/scientificreports www.nature.com/scientificreports/ Airflow in both rooms reached 14-18 air exchanges per hour, according to airflow velocity measurements with an anemometer (EBT731 Balometer; TSI Alnor ® , Minnesota, United States). In this environment, removing airborne contaminants requires 18 minutes for 99% efficiency and 28 minutes for 99.9% efficiency 16 . Therefore, 30 minutes of room ventilation was required after aerosol forming high-risk procedures, such as endotracheal intubation or extubation 12, 17 . The cleanliness level of each room was also measured using a particle counter (TSI 9310; TSI, United States): main operating room = 2,604 and the anteroom = 2,540, which were much lower than the institutional target level of <10,000 for general surgery (Fig. 3) . Cleanliness level was defined as the number of particles smaller than 0.5 µm in 0.3048 m 3 . Equipment preparation and disinfection. All built-in instruments such as computers, telephones, and ventilators were covered with plastic paper. Sufficient amounts of drugs, fluids, and other equipment were prepared in the operating room before surgery, and other unnecessary equipment was moved out. Additionally, we used disposable equipment, when possible. High efficiency particulate air (HEPA) filters were installed in the breathing circuits, both on the inspiratory and expiratory limbs of the ventilators and at the patient's site that connected to endotracheal tube. After operations with MERS-exposed patients, 30 minutes of room ventilation was followed by surface disinfection with diluted chlorine bleach (500 ppm) 18, 19 . Cleaners wore standard PPE while disinfecting surfaces. For MERS-confirmed patients, surface disinfection was performed twice.

Institutional guidelines for perioperative management of MERS-related patients. During the MERS outbreak, we set the following principles for perioperative management of MERS-related patients: All elective surgeries for MERS-confirmed patients were postponed to reduce the risk of potential in-hospital transmission. For MERS-exposed patients, surgical procedures were delayed until after the potential incubation period of 14 days 20 . When a MERS-related patient required an urgent or emergency operation, MERS-CoV PCR tests were performed twice with distinct specimens preoperatively, to account for asymptomatic MERS patients or delayed positive conversion in symptomatic MERS-exposed patients. For patients with ambiguous PCR results or without a PCR test, operations were performed according to the management guidelines for MERS-confirmed patients. All the surgical procedures for MERS-related patients were performed in the last order of the day as possible.

Perioperative protection level for HCWs. When an operation for a MERS-related patient was scheduled, the Division of Infectious Diseases and Infection Control Department confirmed the protection level of the HCWs, according to institutional guidelines (Table 1 ). In principle, standard PPE was applied to HCWs who cared for asymptomatic MERS-exposed patients. Standard PPE includes surgical gloves, surgical gowns, eye shields, and N95 respirators. While managing MERS-confirmed or MERS-exposed patients with MERS-associated symptoms including fever, myalgia, respiratory symptoms, or diarrhea, HCWs implemented enhanced PPE, which included coverall clothes with head cover, shoe covers, goggles, two pairs of surgical gloves, and powered air purifying respirator (PAPR) or N95 respirators. Although we performed preoperative MERS-CoV PCR screening, enhanced PPE was still recommended when managing symptomatic MERS-exposed patients regardless of their PCR results. Anesthesiologists were recommended to apply enhanced PPE (including PAPR from the middle of the outbreak) when managing all MERS-related patients because they were most directly exposed to the aerosol-producing high-risk procedures, such as endotracheal intubation and extubation. Only minimal numbers of HCWs were present in the operating room. Institutional education regarding the precise use of PPE was provided to the all associated HCWs and they were assisted by skilled nurses in the operating room during the PPE donning and doffing processes.

Patient transfer for operation. MERS-related patients were transferred directly to the negative-pressure main operating room through an exclusive path and elevator by a physician wearing proper PPE. The walls and the floor of the passageways and the elevator were covered with plastic paper. MERS-related patients wore a www.nature.com/scientificreports www.nature.com/scientificreports/ surgical mask during transfer. Because only anesthesiologists wore enhanced PPE when in proximity to asymptomatic MERS-exposed patients, 30 minutes of room ventilation was performed after anesthetic induction, including endotracheal intubation. The surgical team then entered the main operating room through the anteroom. In the cases of symptomatic MERS-exposed patients or MERS-confirmed cases, all HCWs wore enhanced PPE and the 30-minute ventilation time was not required.

After completion of operation procedures, patients who were moved to the general ward recovered in the main operating room without going through the post-anesthesia care unit. Thirty minutes of room ventilation was performed after tracheal extubation. A physician in the main operating room sent the patient into the corridor, while the other physician outside the main operating room wearing PPE took over and transferred the patient to the general ward directly through the exclusive pathway (Fig. 4) . Patients moving to the intensive care unit (ICU) were transferred while remaining intubated. Before transfers, we injected patients with a sufficient amount of intravenous muscle relaxant and sedative drugs to prevent coughing or movement and we applied a portable ventilator or bag-valve mask with a HEPA filter to the patient.

Operations for six MERS-related patients. The details of the six MERS-related patients undergoing surgery are presented in Table 2 . Two patients had operations during phase 1 and four patients during phase 2 of the outbreak (Fig. 1) . The negative-pressure operating room was set up to be used from phase 2. Regarding PPE levels for the HCWs attending these six patients, standard PPE was applied during management of patient A (asymptomatic MERS-exposed patient), while anesthesiologists wore enhanced PPE for high-risk procedures (tracheal intubation). Enhanced PPE was applied to HCWs for patient B because the patient was symptomatic and still within the two-week incubation period, even though both PCR results were negative. Enhanced PPE, including PAPR to reduce risk of MERS-transmission, was applied for patient C who underwent surgery in the middle of the outbreak (phase 2). PAPR provides more perfect sealing and protection of the head surface.

Patients D and E had documented MERS-CoV infection and their recovery was confirmed with symptom resolution and two negative MERS-CoV PCR tests. However, enhanced PPE with PAPR was applied to HCWs because the infection risk could not be eliminated during exposure to a large amount of body fluid, especially during Cesarean section (patient D). After spinal anesthesia, she recovered in the main operating room and was transferred directly to the general ward. Patient F had a history of exposure to a MERS patient in the emergency room and was isolated due to a fever. Enhanced PPE was applied to the HCWs for patient F and she underwent surgery with only one set of negative PCR results because of her emergency condition. 

MERS, as well as SARS, is associated with coronaviruses, both of which have high affinity for the lower repiratory tract and easily produce severe pneumonia [21] [22] [23] [24] [25] . Although MERS has lower human-to-human transmission potential and has resulted in fewer large outbreaks than SARS, there may be occasional amplification of clusters in healthcare settings [21] [22] [23] . Moreover, MERS case fatalities are reported to be much higher than SARS (35-45% for MERS and 10-15% for SARS) 12, 17, 23, 24, 26 . Unlike SARS, ongoing small and large MERS outbreaks in the Arabian Peninsula foster potential future MERS outbreaks in non-endemic countries. However, there is likely to be a very limited number of hospitals that are prepared with negative-pressure operating rooms, except for a few hospitals in Hong Kong that experienced the 2003 SARS outbreak 13 . Almost all hospitals generally have positive-pressure operating rooms and they may experience an outbreak without facilities that are prepared for perioperative management of MERS patients, as our hospital did in 2015.

One of the highlights of our experience during the outbreak was the temporary set-up of a negative-pressure operation room with an adequate pressure gradient (≥2.5 Pa) by modifying two connected operating rooms according to US Centers for Disease Control and Prevention (CDC) guidelines 15 . Continuous negative pressure was maintained in the main operating room (−4.7 Pa) and the anteroom (−1.2 Pa). This temporary setting was possible because the two adjacent rooms had separate atmospheric air inlets and exhaust systems. Although we could not measure the airflow pattern or dispersion of infectious particles directly 27 , the cleanliness levels in both operating rooms were 2,500 particles, well below the institutional target cleanliness for general surgery (<10,000 particles).

Although the precise route of MERS-virus transmission is currently not clearly understood 21 , MERS, as well as SARS, is known to spread by direct contact with infectious material, such as large respiratory droplets, and also by airborne routes 28, 29 . Touching contaminated objects may also be a source of transmission; this is different from tuberculosis, which is transmitted by airborne routes 19, 29 . Therefore, when performing procedures that generate aerosols, such as endotracheal intubation, in patients with MERS or SARS, HCWs must wear enhanced PPE, including gloves, a gown, either a face-shield that fully covers the front and sides of the face or goggles, and respiratory protection at least as protective as an N95 filtering face piece respirator 19, 28, 30 . When removing PPE, care should also be taken not to contact contaminated materials. Considering potential aerosol generation in operating rooms and the transmission risk of MERS-CoV while changing PPE, the temporary modification of an operating room to a negative-pressure room with an anteroom should provide suitable protection for HCWs participating in operations on MERS-related patients 5 .

A second highlight of our experience is the highly conservative application of PPE to HCWs. At the time of the outbreak, there were no specific guidelines for perioperative management 31 . Therefore, we used a conservative approach based on our experience and previous reports. First, although the previous guidelines recommended that asymptomatic MERS-exposed patients be managed as general patients undergoing surgery, we applied standard PPE to HCWs and we performed MERS-CoV PCR screening twice. Although MERS progressed gradually after symptom onset 32 , we could not exclude the possibility that asymptomatic MERS-exposed patients had the potential to develop symptomatic disease perioperatively. Moreover, we observed development of MERS after the known incubation period of 14 days in an immunocompromised host 10, 33 ; thus, the possibility of exceptional cases could be considered. Furthermore, a certain proportion of asymptomatic MERS-exposed patients could actually be asymptomatic MERS-infected patients. Approximately 21% of laboratory confirmed MERS patients have been classified as asymptomatic or having nonspecific mild symptoms at the time of testing 34 . The potential for transmission from asymptomatic MERS-CoV PCR-positive person is currently unknown, but there are reports about prolonged viral RNA detection in the upper respiratory tract in asymptomatic PCR-positive person 9 . Considering these points, it would be reasonable to prepare more conservatively than the existing guidelines call for. www.nature.com/scientificreports www.nature.com/scientificreports/ Another point on which our preparations differed from the guidelines was the application of enhanced PPE, which emphasizes full protection of the body surface with a hooded coverall. During the outbreak in our hospital, MERS transmission events occurred among HCWs who were equipped with standard PPE, including N95 masks. Transmission may have occurred after possible contamination of uncovered head or face surfaces 35 . Therefore, if a patient with a MERS contact history had MERS-associated symptoms, applying enhanced PPE (either a N95 respirator or PAPR) during surgery would be appropriate for HCWs because numerous droplets and aerosols may be produced during airway interventions. Because the N95 may fit inadequately if worn for a long time or after movement during surgery, wearing PAPR will be more beneficial. However, unlike HCWs dealing with Ebola virus, impermeable and fluid-resistant gowns are not required because body fluids are not infectious as with Ebola virus diseases 9, 28, 35, 36 .

Our experience was limited in that, as a MERS outbreak outside the endemic country, we did not have an opportunity to perform surgical procedures in actively virus-shedding MERS-infected patients. Additionally, our infection-prevention protocols would be too conservative to apply in MERS-endemic situations. However, considering the potential risk of infected HCWs, preventing MERS transmission is extremely important in the management of a MERS outbreak. Importantly, our experience can be generalized to other non-endemic countries for managing potential outbreaks of emerging respiratory diseases.

In the era of globalization, a MERS outbreak can occur in any country outside the Middle East. A very limited number of hospitals are equipped with negative-pressure operating rooms, and therefore, most hospitals are likely to experience a MERS or other outbreak in an unprepared circumstance. We hope that this report will help other hospitals in preparing for future MERS outbreaks and infection control in unexpected conditions.

This study was based on all available data at the Samsung Medical Center from the MERS outbreak and on interviews with HCWs associated with the outbreak. The study was approved by Samsung Medical Center Institutional Review Board. The documents for review included electronic medical records of MERS-related patients who underwent operative procedures and institutional guidelines for perioperative management of MERS-related surgical patients. The MERS guidelines were prepared through multidisciplinary team discussions that were held by our hospital's infection control department during and after the MERS outbreak. The records about the temporary set-up of a negative-pressure operating room were also reviewed. We also collected data through interviews with HCWs who participated in surgery and anesthesia for MERS-related patients.

We defined MERS-related patients as those who were possibly or directly exposed to MERS or who had a previously confirmed MERS diagnosis 10 . In brief, patients who had a potential but unconfirmed close contact history with a MERS patient were defined as possibly exposed patients, and they were allowed to continue their normal activities until MERS-like symptoms developed. Directly exposed patients included those who had close contact with a known MERS patient and who did not wear proper PPE; these patients were isolated in their homes or in private negative-pressure rooms at our hospital.

Because the number of MERS-infected patients continuously increased at our hospital, we partially closed the hospital on June 13 10 , at which point outpatient-care clinics were closed and the emergency department was only available for life-threatening emergencies. All elective surgeries were postponed if possible 10 . We defined the early phase of the outbreak (before June 13) as phase 1 and the middle phase of the outbreak (from June 13) as phase 2.

For MERS-CoV PCR tests, either sputum or nasopharyngeal swab samples were collected and sputum samples were preferred if available 14 . Sputum was collected directly into a sterile, leak-proof, screw-capped sputum collection sterile container and nasopharyngeal swab was collected with an eSwab (482 C, Copan Diagnostics Inc., Murrieta, CA, USA). Clinical samples were screened by rRT-PCR testing with amplification targeting the upstream E region (upE) and confirmed by subsequent amplification of the open reading frame (ORF)1a using

PowerChek ™ MERS real-time PCR kits (Kogene Biotech, Seoul, Korea). All rRT-PCR reactions were performed using the 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The PCR reaction was performed in a total volume of 20 μL (15 μL PCR reaction mixture and 5 μL template RNA). Thermocycling conditions included a step at 50 °C for 30 min, followed by 95 °C for 10 min and then 40 cycles of 15 s at 95 °C and 60 s at 60 °C. Positive viral template control and no-template control were included in each run. The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was amplified simultaneously as a heterologous internal control to monitor PCR inhibition. A positive test result was defined as a well-defined exponential fluorescence curve that crossed the cycle threshold (Ct) < 35 cycles for both upE and ORF1a. A sample was considered "equivocal" if the upE result was positive but the Ct value for ORF1a was >35 and <40. We interpreted the result as "indeterminate" if (1) the upE result was positive but the Ct value for ORF1a was undetected or if (2) the Ct value for upE was >35 and <40.

Institutional review board statement. The study was performed in accordance with the declaration of Helsinki and experimental protocols were revised and approved by IRB at Samsung Medical Center. (IRB No. SMC 2016-08-156-002).

Informed consent statement. IRB at Samsung Medical Center has approved the waiver of patient consent form because of the retrospective nature of this study. Patient confidentiality is maintained at all time in accordance with Samsung Medical Center policies.

Middle East respiratory syndrome: new disease, old lessons

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Contact investigation for imported case of Middle East respiratory syndrome

Enhanced MERS coronavirus surveillance of travelers from the Middle East to England

Laboratory-confirmed case of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Malaysia: preparedness and response

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities

Family cluster of Middle East respiratory syndrome coronavirus infections

Euro surveillance: Bull. Europeen sur les. maladies transmissibles = European communicable Dis

Ebola virus disease: an update for anesthesiologists and intensivists

Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea

MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study

Infection control measures for operative procedures in severe acute respiratory syndrome-related patients

Conversion of operating theatre from positive to negative pressure environment

Importance of Specimen Type and Quality in Diagnosing Middle East Respiratory Syndrome

Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC)

Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings

Infection control and anesthesia: lessons learned from the Toronto SARS outbreak

Effects of environmental disinfection on the isolation of vancomycin-resistant Enterococcus after a hospital-associated outbreak of Middle East respiratory syndrome

Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities

Surveillance for human infection with Middle East respiratory syndrome coronavirus (MERS-CoV), Interim guidance

Severe acute respiratory syndrome vs. the Middle East respiratory syndrome

MERS coronavirus: diagnostics, epidemiology and transmission

Transmission characteristics of MERS and SARS in the healthcare setting: a comparative study

Middle East respiratory syndrome

Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore

Middle East respiratory syndrome coronavirus in healthcare settings

Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care, WHO Guidelines

Guidance on Personal Protective Equipment (PPE) To Be Used By Healthcare Workers during Management of Patients with Confirmed Ebola or Persons under Investigation (PUIs) for Ebola who are Clinically Unstable or Have Bleeding, Vomiting, or Diarrhea in U.S. Hospitals, Including Procedures for Donning and Doffing PPE, page last reviewed on August 30

Guidelines for preventing the transmission of mycobacterium tuberculosis in healthcare settings

Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection, Interim guidance

Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients

Atypical presentations of MERS-CoV infection in immunocompromised hosts

Management of asymptomatic persons who are RTPCR positive for Middle East respiratory syndrome coronavirus (MERS-CoV), Interim Guidance

Serologic Evaluation of MERS Screening Strategy for Healthcare Personnel During a Hospital-Associated Outbreak

Surgical Protocol for Possible or Confirmed Ebola Cases

Anesthetic Implications of Ebola Patient Management: A Review of the Literature and Policies

J.P. This author helped with data collection, data analysis, writing of the first draft and revision of the manuscript, and archiving of the study files. S.Y.Y. This author helped with data analysis, discussion of results, writing and revision of the manuscript, archiving of the study files and approval of final version. J. 

The authors declare no competing interests.

Correspondence and requests for materials should be addressed to K.R.P. or J.J.M.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.